Showing results (111-120 of 168) with videos related to
Sort By:
Pageof 17
Nature Communications|September 26, 2022
The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systemsKeren Lasker, Steven Boeynaems, Vinson Lam, et al.Antiviral Therapy|February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.European Journal of Medicinal Chemistry|June 26, 2018
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integraseLin Sun, Ping Gao, Guanyu Dong, et al.European Journal of Medicinal Chemistry|August 16, 2015
Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residueZheng-Yong Wan, Jin Yao, Tian-Qi Mao, et al.ACS Medicinal Chemistry Letters|November 21, 2017
Discovery of Thiophene[3,2-<i>d</i>]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBPDongwei Kang, Xiao Ding, Gaochan Wu, et al.European Journal of Medicinal Chemistry|April 11, 2018
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virusYe Tian, Zhaoqiang Liu, Jinghan Liu, et al.Chemical Biology & Drug Design|November 2, 2018
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions IDongwei Kang, Zhao Wang, Meng Chen, et al.Journal of Medicinal Chemistry|August 20, 2016
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance ProfilesDongwei Kang, Zengjun Fang, Zhenyu Li, et al.Bioorganic & Medicinal Chemistry|February 26, 2025
Optimizing biofilm inhibitors: Balancing activity and toxicity in 2N-aminated 5-aryl-2-aminoimidazolesLynn Maetens, Banibrata Maiti, Freya Cools, et al.Biochemical Pharmacology|July 25, 2024
Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cellsKristof De Vos, Adamantios Mavrogiannis, Justina Clarinda Wolters, et al.Pageof 17